(Q45017091)

8 December 2017

Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment (English)

1 reference

8 December 2017

Murad Atmaca

1

1 reference

8 December 2017

E Tezcan

2

1 reference

8 December 2017

M Kuloglu

3

1 reference

8 December 2017

B Ustundag

4

1 reference

8 December 2017

H Tunckol

5

1 reference

8 December 2017

1 August 2004

1 reference

European Archives of Psychiatry and Clinical Neuroscience

8 December 2017

1 reference

8 December 2017

254

1 reference

8 December 2017

4

1 reference

8 December 2017

231-235

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-004-0484-3

8 December 2017

0 references

1 reference

12 December 2020

Free radical pathology and antioxidant defense in schizophrenia: a review

1 reference

12 December 2020

Assay for blood plasma or serum

1 reference

12 December 2020

A simple method for clinical assay of superoxide dismutase

1 reference

12 December 2020

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

12 December 2020

Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.

1 reference

12 December 2020

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

12 December 2020

Reduced level of plasma antioxidant uric acid in schizophrenia.

1 reference

12 December 2020

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

1 reference

12 December 2020

Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase

1 reference

12 December 2020

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

12 December 2020

Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment

1 reference

12 December 2020

Antioxidant enzyme and malondialdehyde levels in patients with social phobia

1 reference

12 December 2020

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

1 reference

12 December 2020

Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder

1 reference

12 December 2020

Effect of oxidative stress on receptors and signal transmission

1 reference

12 December 2020

Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method

1 reference

12 December 2020

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments

1 reference

12 December 2020

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

1 reference

12 December 2020

Inhibitors of imipramine metabolism by human liver microsomes

1 reference

12 December 2020

Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine

1 reference

12 December 2020

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

1 reference

12 December 2020

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

1 reference

12 December 2020

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

12 December 2020

Lipid peroxidation and antioxidants as biomarkers of tissue damage

1 reference

12 December 2020

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

12 December 2020

Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones

1 reference

12 December 2020

Protein oxidation and aging

1 reference

12 December 2020

Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram

1 reference

12 December 2020

Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.

1 reference

12 December 2020

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Elimination of ascorbic acid-induced membrane lipid peroxidation and serotonin receptor loss by Trolox-C, a water soluble analogue of vitamin E

1 reference

12 December 2020

10.1007/S00406-004-0484-3

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1039089509

0 references

Fatcat ID

release_fkeinfnvzzf4hb2fyrl2nxm3k4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fkeinfnvzzf4hb2fyrl2nxm3k4

24 November 2022

mapped directly with Wikidata item

1 reference